Results 41 to 50 of about 4,842 (209)

Inhibition of Phosphodiesterase-4 Reverses Aβ-Induced Memory Impairment by Regulation of HPA Axis Related cAMP Signaling

open access: yesFrontiers in Aging Neuroscience, 2018
Beta amyloid peptides (Aβ) are found to be associated with dysfunction of hypothalamic-pituitary-adrenal axis (HPA axis) that leads to memory and cognitive deficits in patients with Alzheimer's disease (AD). Phosphodiesterase 4 (PDE4) inhibitors increase
Ying Xu   +12 more
doaj   +1 more source

Inhibition of the upregulated phosphodiesterase 4D isoforms improves SERCA2a function in diabetic cardiomyopathy

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 7, Page 1487-1507, April 2025.
Abstract Background and Purpose Sarcoplasmic reticulum Ca2+‐ATPase (SERCA2a) is impaired in heart failure. Phosphodiesterases (PDEs) are implicated in the modulation of local cAMP signals and protein kinase A (PKA) activity essential for cardiac function.
Zhenduo Zhu   +11 more
wiley   +1 more source

Cross‐pathway integration of cAMP signals through cGMP and calcium‐regulated phosphodiesterases in mouse striatal cholinergic interneurons

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 5, Page 1236-1253, March 2025.
Abstract Background and Purpose Acetylcholine plays a key role in striatal function. Firing properties of striatal cholinergic interneurons depend on intracellular cAMP through the regulation of Ih currents. Yet, the dynamics of cyclic nucleotide signalling in these neurons have remained elusive.
Ségolène Bompierre   +7 more
wiley   +1 more source

The Effects of a Selective cAMP Phosphodiesterase Inhibitor, Rolipram, on Methamphetamine-Induced Behavior [PDF]

open access: yesNeuropsychopharmacology, 1995
The effects of rolipram, a selective cAMP phosphodiesterase inhibitor, on locomotor activity, rearing, and stereotyped behavior (sniffing, repetitive head movements) induced by methamphetamine (MAP) over 1 hour were investigated in rats. Coadministration of rolipram (4 mg/kg IP) significantly attenuated the responses of locomotor activity, rearing and ...
Toshiya Inada   +5 more
openaire   +3 more sources

Visible Light‐Mediated Decarboxylative Giese Addition Utilizing Thioxanthone or Thioxanthone‐TfOH Complex as the Photocatalyst

open access: yesChemistry – A European Journal, Volume 31, Issue 12, February 25, 2025.
Photochemistry: A cheap, metal‐free, photochemical protocol for the 1,4‐decarboxylative addition between carboxylic acids and electron‐deficient olefins, under irradiation at 427 nm, utilizing the cheap, metal‐free, commercially available, thioxanthone or thioxanthone‐TfOH complex as the suitable photocatalyst.
Charikleia S. Batsika   +2 more
wiley   +1 more source

Lipidic nanocapsule drug delivery: neuronal protection for cochlear implant optimization

open access: yesInternational Journal of Nanomedicine, 2012
Hartwig Meyer,1,2 Timo Stöver,1,3 Florian Fouchet,4 Guillaume Bastiat,4 Patrick Saulnier,4 Wolfgang Bäumer,2 Thomas Lenarz,1 Verena Scheper,11Department of Otolaryngology, Hannover Medical School, 2Institute for Pharmacology, Toxicology
Meyer H   +7 more
doaj  

Combining Neurotrophin-Transduced Schwann Cells and Rolipram to Promote Functional Recovery from Subacute Spinal Cord Injury

open access: yesCell Transplantation, 2013
Following spinal cord injury (SCI), both an inhibitory environment and lack of intrinsic growth capacity impede axonal regeneration. In a previous study, prevention of cyclic adenosine monophosphate (AMP) hydrolysis by the phosphodiesterase-4 inhibitor ...
Govinder Flora   +10 more
doaj   +1 more source

Reversing Alzheimer's disease dementia with clemastine, fingolimod, or rolipram, plus anti‐amyloid therapy

open access: yesAlzheimer’s & Dementia: Translational Research & Clinical Interventions, 2022
A few anti‐amyloid trials offer a slight possibility of preventing progression of cognitive loss, but none has reversed the process. A possible reason is that amyloid may be necessary but insufficient in the pathogenesis of AD, and other causal factors ...
Jeffrey Fessel
doaj   +1 more source

Malnutrition exacerbating neuropsychiatric symptoms on the Alzheimer's continuum is relevant to the cAMP signaling pathway: Human and mouse studies

open access: yesAlzheimer's &Dementia, Volume 21, Issue 2, February 2025.
Abstract INTRODUCTION Malnutrition correlates with neuropsychiatric symptoms (NPSs) in Alzheimer's disease (AD); however, the potential mechanism underlying this association remains unclear. METHODS Baseline and longitudinal associations of nutritional status with NPSs were analyzed in 374 patients on the AD continuum and 61 healthy controls.
Jiwei Jiang   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy